Page last updated: 2024-08-21

pyrazines and lactic acid

pyrazines has been researched along with lactic acid in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (21.05)18.2507
2000's4 (21.05)29.6817
2010's10 (52.63)24.3611
2020's1 (5.26)2.80

Authors

AuthorsStudies
Beck-Nielsen, H; Damsbo, P; Gall, MA; Richter, EA; Skött, P; Vaag, A1
Beck-Nielsen, H; Henriksen, JE; Melander, A; Thye-Rønn, P; Vaag, A; Worm, D1
Iwasa, S; Kurokawa, T; Miyazaki, K; Ogawa, Y; Takada, S1
Bowness, RJ; Hardman, AE; Macdonald, IA; Malkova, D1
Choong, B; Cooney, GJ; Cooper, GJ; Iglesias, MA; Kraegen, EW; Lim-Fraser, M; Watson, DG; Ye, JM1
Matzinger, O; Schneiter, P; Tappy, L1
Ackermans, MT; canh Hung, N; Endert, E; Kager, PA; Sauerwein, HP; van Thien, H; Weverling, GJ1
Christiansen, JS; Jørgensen, JO; Møller, N; Nielsen, S; Nørrelund, H1
DeYoung, MB; Herbert, P; MacConell, L; Sarin, V; Trautmann, M1
Cochran, MC; Eisenbrey, JR; Oum, KL; Wheatley, MA1
Cui, W; Li, H; Liu, L; Lv, J; Zhang, S1
Gryczynski, Z; Ranjan, AP; Raut, SL; Thamake, SI; Vishwanatha, JK1
Fujiwara, S; Hata, H; Kawano, Y; Mitsuya, H; Nosaka, K; Okuno, Y; Yuki, H1
Baron, R; Basto, P; Bertrand, N; Farokhzad, OC; Ghobrial, IM; Glavey, S; Kamaly, N; Liu, J; Lu, ZN; Manier, S; Memarzadeh, M; Mishima, Y; Moschetta, M; Nagano, K; Reagan, MR; Roccaro, AM; Sacco, A; Seevaratnam, D; Shi, J; Swami, A; Wu, J; Zhang, S; Zhang, Y1
Almeida, GM; Coelho, MA; Frasco, MF; Pereira, Mdo C; Santos-Silva, F1
Ma, P; Mu, H; Sun, K; Wang, A; Wei, J; Wu, Z; Zhang, L; Zhang, X1
Dong, XX; Fu, J; Li, FW; Ni, J; Yin, XB; Zeng, ZP1
Hansen, D; Minten, L; Smeets, K; van Dijk, JW; van Loon, LJC; Verboven, K; Verdijk, LB; Zorenc, A1
Calpe, J; Dopazo, V; Luz, C; Mañes, J; Meca, G; Quiles, JM; Romano, R1

Reviews

1 review(s) available for pyrazines and lactic acid

ArticleYear
Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.
    Diabetes technology & therapeutics, 2011, Volume: 13, Issue:11

    Topics: Adult; Blood Glucose; Capsules; Diabetes Mellitus, Type 2; Exenatide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin Glargine; Insulin, Long-Acting; Lactic Acid; Peptides; Pioglitazone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles; Venoms

2011

Trials

5 trial(s) available for pyrazines and lactic acid

ArticleYear
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
    The Journal of clinical endocrinology and metabolism, 1994, Volume: 78, Issue:3

    Topics: Blood Glucose; Blood Pressure; Cholesterol; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Humans; Hypolipidemic Agents; Insulin; Lactates; Lactic Acid; Male; Middle Aged; Osmolar Concentration; Placebos; Pyrazines; Time Factors

1994
The reduction in postprandial lipemia after exercise is independent of the relative contributions of fat and carbohydrate to energy metabolism during exercise.
    Metabolism: clinical and experimental, 1999, Volume: 48, Issue:2

    Topics: Adult; Blood Glucose; Body Mass Index; Carbohydrate Metabolism; Catecholamines; Eating; Energy Metabolism; Exercise; Exercise Test; Fats; Fatty Acids, Nonesterified; Glycogen; Humans; Hypolipidemic Agents; Lactic Acid; Lipids; Male; Postprandial Period; Pyrazines; Triglycerides

1999
Effects of fatty acids on exercise plus insulin-induced glucose utilization in trained and sedentary subjects.
    American journal of physiology. Endocrinology and metabolism, 2002, Volume: 282, Issue:1

    Topics: Adult; Bicycling; Blood Glucose; Calorimetry, Indirect; Carbohydrate Metabolism; Exercise; Fatty Acids; Fatty Acids, Nonesterified; Glucose; Humans; Hypolipidemic Agents; Insulin; Lactic Acid; Life Style; Lipid Metabolism; Lipids; Osmolar Concentration; Oxidation-Reduction; Physical Education and Training; Physical Endurance; Pyrazines; Reference Values

2002
FFAs are not involved in regulation of gluconeogenesis and glycogenolysis in adults with uncomplicated P. falciparum malaria.
    American journal of physiology. Endocrinology and metabolism, 2004, Volume: 287, Issue:4

    Topics: Adult; Alanine; Fatty Acids, Nonesterified; Female; Gluconeogenesis; Glucose; Glycogen; Humans; Hypolipidemic Agents; Insulin; Interleukin-10; Lactic Acid; Malaria, Falciparum; Male; Pyrazines; Tumor Necrosis Factor-alpha

2004
Adipose tissue lipolytic inhibition enhances the glucoregulatory properties of exercise in type 2 diabetes patients.
    European journal of sport science, 2018, Volume: 18, Issue:9

    Topics: Adipose Tissue; Administration, Oral; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Exercise; Fatty Acids; Glycogen; Humans; Hypolipidemic Agents; Insulin; Lactic Acid; Lipid Metabolism; Male; Middle Aged; Pyrazines; Triglycerides

2018

Other Studies

13 other study(ies) available for pyrazines and lactic acid

ArticleYear
Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus.
    The Journal of clinical investigation, 1991, Volume: 88, Issue:4

    Topics: Biological Transport; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Glucose; Glycogen Synthase; Humans; Hypolipidemic Agents; Lactates; Lactic Acid; Lipid Metabolism; Middle Aged; Muscles; Oxidation-Reduction; Pyrazines; Pyruvate Dehydrogenase Complex

1991
Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres.
    Pharmaceutical research, 1997, Volume: 14, Issue:9

    Topics: Animals; Arginine; Biocompatible Materials; Drug Delivery Systems; Fibrinolytic Agents; Guanidines; Lactic Acid; Male; Microspheres; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazines; Rats; Rats, Sprague-Dawley

1997
Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 280, Issue:4

    Topics: Amyloid; Animals; Blood Glucose; Hypolipidemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Lactic Acid; Lipids; Lipolysis; Liver; Male; Muscle, Skeletal; Peptide Fragments; Pyrazines; Rats; Rats, Wistar; Triglycerides

2001
Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.
    European journal of endocrinology, 2004, Volume: 150, Issue:6

    Topics: Adult; Amino Acids; Blood Flow Velocity; Blood Glucose; Calorimetry, Indirect; Fasting; Fatty Acids, Nonesterified; Forearm; Glucagon; Glucose Clamp Technique; Glycerol; Human Growth Hormone; Humans; Insulin; Insulin Resistance; Lactic Acid; Lipolysis; Male; Microdialysis; Plethysmography; Pyrazines; Somatostatin

2004
Cellular signal transduction can be induced by TRAIL conjugated to microcapsules.
    Journal of biomedical materials research. Part A, 2012, Volume: 100, Issue:10

    Topics: Annexin A5; Apoptosis; Boronic Acids; Bortezomib; Capsules; Cell Line, Tumor; Contrast Media; Doxorubicin; Flow Cytometry; Humans; Lactic Acid; Melanoma; Membranes, Artificial; Particle Size; Polyesters; Polymers; Pyrazines; Signal Transduction; Staining and Labeling; TNF-Related Apoptosis-Inducing Ligand; Ultrasonics

2012
Identification of antifungal compounds produced by Lactobacillus casei AST18.
    Current microbiology, 2012, Volume: 65, Issue:2

    Topics: Antifungal Agents; Chromatography, High Pressure Liquid; Culture Media; Dipeptides; Gas Chromatography-Mass Spectrometry; Hydrogen-Ion Concentration; Lactic Acid; Lacticaseibacillus casei; Peptides, Cyclic; Piperidines; Pyrazines; Temperature; Ultrafiltration

2012
Alendronate coated poly-lactic-co-glycolic acid (PLGA) nanoparticles for active targeting of metastatic breast cancer.
    Biomaterials, 2012, Volume: 33, Issue:29

    Topics: Alendronate; Animals; Antineoplastic Agents; Bone and Bones; Bone Neoplasms; Boronic Acids; Bortezomib; Breast Neoplasms; Curcumin; Drug Carriers; Female; Humans; Lactic Acid; Mice; Mice, Nude; Nanoparticles; Neoplasm Metastasis; Osteoporosis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines

2012
PDK1 inhibition is a novel therapeutic target in multiple myeloma.
    British journal of cancer, 2013, Jan-15, Volume: 108, Issue:1

    Topics: Boronic Acids; Bortezomib; Cell Line, Tumor; Dichloroacetic Acid; Glucose; Glycolysis; Humans; Lactate Dehydrogenases; Lactic Acid; Molecular Targeted Therapy; Multiple Myeloma; Protein Serine-Threonine Kinases; Pyrazines; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA, Small Interfering

2013
Engineered nanomedicine for myeloma and bone microenvironment targeting.
    Proceedings of the National Academy of Sciences of the United States of America, 2014, Jul-15, Volume: 111, Issue:28

    Topics: Alendronate; Animals; Antineoplastic Agents; Bone Neoplasms; Boronic Acids; Bortezomib; Cell Line, Tumor; Drug Delivery Systems; Heterografts; Humans; Lactic Acid; Mice; Mice, Inbred BALB C; Mice, Nude; Multiple Myeloma; Nanoparticles; Neoplasm Transplantation; Neoplasms, Experimental; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Tumor Microenvironment; Xenograft Model Antitumor Assays

2014
Transferrin surface-modified PLGA nanoparticles-mediated delivery of a proteasome inhibitor to human pancreatic cancer cells.
    Journal of biomedical materials research. Part A, 2015, Volume: 103, Issue:4

    Topics: Boronic Acids; Bortezomib; Cell Death; Cell Line, Tumor; Endocytosis; Humans; Lactic Acid; Nanoparticles; Pancreatic Neoplasms; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Proteasome Inhibitors; Pyrazines; Spectroscopy, Fourier Transform Infrared; Telomerase; Transferrin

2015
Preparation and evaluation of a novel biodegradable long-acting intravitreal implant containing ligustrazine for the treatment of proliferative vitreoretinopathy.
    The Journal of pharmacy and pharmacology, 2015, Volume: 67, Issue:2

    Topics: Absorbable Implants; Animals; Biocompatible Materials; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Lactic Acid; Male; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Pyrazines; Rabbits; Retina; Vitreoretinopathy, Proliferative; Vitreous Body

2015
Preparation and physicochemical characterization of T-OA PLGA microspheres.
    Chinese journal of natural medicines, 2017, Volume: 15, Issue:12

    Topics: Antineoplastic Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Oleanolic Acid; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction

2017
Potential application of lactic acid bacteria in the biopreservation of red grape from mycotoxigenic fungi.
    Journal of the science of food and agriculture, 2022, Volume: 102, Issue:3

    Topics: Food Contamination; Food Preservation; Fruit; Fungi; Fungicides, Industrial; Lactates; Lactic Acid; Lactobacillus plantarum; Pyrazines; Vitis

2022